The global ureteral stents market size was valued at USD 423 billion in 2019 and is expected to reach USD 749 billion by 2028, expanding at a CAGR of 6.0% during the forecast period, 2021 – 2028. The growth of the market is attributed to the increasing cases of urological and kidney-related disorders.
The surgical microscope market is expected to exceed $1,740.4 million by 2026, growing at a CAGR of 12.5%. In 2017, ophthalmic microscopes dominated the market. North America accounted for the largest share due to increasing healthcare spending and surgical procedures. Key growth drivers include rising disease prevalence, technological advancements, and growing geriatric populations. Major players are expanding through acquisitions and new product development to capitalize on the market opportunity in both developed and emerging countries.
The document summarizes the work experience and responsibilities of an analyst in the medical device industry. Key responsibilities included conducting primary and secondary research through interviews and data collection to analyze market dynamics, trends, and growth forecasts for medical devices. Reports were written on various medical device markets such as arthroscopy devices, orthopedic joint replacement, ultrasound devices, MRI, x-rays, and the dental industry. The analyst leveraged relationships with industry executives to provide insights and analyzed factors driving growth in various medical device markets.
Refurbished Medical Imaging Equipment Market To Surpass $21.14 Billion By 202...OliviaThomas57
The global refurbished medical imaging equipment market was valued at USD 11.7 billion in 2019 and size is expected to reach USD 21.14 billion by 2027 to grow at a CAGR of 7.7% during the forecast period
Booming Refurbished Medical Device MarketVikas Gupta
The growth in the refurbished medical device market has been propelled by various drivers and market-enablers, that are transforming the dynamics globally, throwing up a plethora of opportunities for the investors in this segment
The Hospitals and Outpatient Care Centers Market Analytics Report (http://bit.ly/2a34J1U) provides strategists, marketers and senior management with the critical information they need to assess the global hospitals and outpatient care centers and compare it with other markets and across geographies.
Buy Now
Hospitals and Outpatient Care Centers Global Market Analytics Report is a detailed report giving a unique insight into this market. The report is priced at $2000 for an individual user. To use across your office the price is $3000 and $4000 if you wish to use across a multinational company.
Clients are able to input on the design of the report and highlight points of special interest.
Dendreon Corporation is developing novel immunotherapies to treat cancer. It has one product, Provenge, approved for late-stage prostate cancer which works by re-engaging the immune system. While showing promise, Provenge faces challenges of high costs, lengthy approval delays, and lawsuits seeking earlier access. Dendreon needs to diversify its pipeline and pursue financing to support clinical trials and market expansion.
The surgical microscope market is expected to exceed $1,740.4 million by 2026, growing at a CAGR of 12.5%. In 2017, ophthalmic microscopes dominated the market. North America accounted for the largest share due to increasing healthcare spending and surgical procedures. Key growth drivers include rising disease prevalence, technological advancements, and growing geriatric populations. Major players are expanding through acquisitions and new product development to capitalize on the market opportunity in both developed and emerging countries.
The document summarizes the work experience and responsibilities of an analyst in the medical device industry. Key responsibilities included conducting primary and secondary research through interviews and data collection to analyze market dynamics, trends, and growth forecasts for medical devices. Reports were written on various medical device markets such as arthroscopy devices, orthopedic joint replacement, ultrasound devices, MRI, x-rays, and the dental industry. The analyst leveraged relationships with industry executives to provide insights and analyzed factors driving growth in various medical device markets.
Refurbished Medical Imaging Equipment Market To Surpass $21.14 Billion By 202...OliviaThomas57
The global refurbished medical imaging equipment market was valued at USD 11.7 billion in 2019 and size is expected to reach USD 21.14 billion by 2027 to grow at a CAGR of 7.7% during the forecast period
Booming Refurbished Medical Device MarketVikas Gupta
The growth in the refurbished medical device market has been propelled by various drivers and market-enablers, that are transforming the dynamics globally, throwing up a plethora of opportunities for the investors in this segment
The Hospitals and Outpatient Care Centers Market Analytics Report (http://bit.ly/2a34J1U) provides strategists, marketers and senior management with the critical information they need to assess the global hospitals and outpatient care centers and compare it with other markets and across geographies.
Buy Now
Hospitals and Outpatient Care Centers Global Market Analytics Report is a detailed report giving a unique insight into this market. The report is priced at $2000 for an individual user. To use across your office the price is $3000 and $4000 if you wish to use across a multinational company.
Clients are able to input on the design of the report and highlight points of special interest.
Dendreon Corporation is developing novel immunotherapies to treat cancer. It has one product, Provenge, approved for late-stage prostate cancer which works by re-engaging the immune system. While showing promise, Provenge faces challenges of high costs, lengthy approval delays, and lawsuits seeking earlier access. Dendreon needs to diversify its pipeline and pursue financing to support clinical trials and market expansion.
The global immuno-oncology market is expected to exceed USD 38.89 billion by 2025, growing at a CAGR of 21.8%. Immuno-oncology or cancer immunotherapy enhances the body's natural defenses to stop cancer growth by using constituents made by the body or in a lab to improve immune system function. Key treatment approaches include monoclonal antibodies, therapeutic vaccines, checkpoint inhibitors, and cytokines while novel targets under investigation include IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, and more. The market is segmented by tumor type and region, with North America currently being the largest market due to high cancer treatment spending and innovation in immuno-oncology treatments.
The document provides an overview of the diagnostics market in Asia. It notes that the market is expected to grow at a CAGR of 8.5% between 2007-2008 due to factors such as increasing healthcare spending, aging populations, and demand for preventative healthcare tools. The largest regional markets are China, India, and Japan, though all markets are expected to see steady growth. The largest product segments are clinical chemistry, immuno-chemistry, and self-monitoring blood glucose devices.
Stent Market Report: Trends, Forecast and Competitive AnalysisLucintel
Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders. #StentMarket, #Stent
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
The document provides an overview of the diagnostics market in Asia from 2009-2010. It finds that the market is expected to grow at a CAGR of 8.5% due to factors like an aging population, increasing healthcare spending, and a shift toward preventative care. The largest national markets are China, expected to grow at 14.5% CAGR, and India at 12.1% CAGR. Leading segments are immunoassay, clinical chemistry and self-monitoring of blood glucose. Emerging areas of growth include molecular diagnostics, point-of-care testing and laboratory automation.
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body.
The global immuno-oncology market is expected to reach $38.89 billion by 2025, growing at a CAGR of 21.8%. Immuno-oncology harnesses the immune system to fight cancer through approaches like monoclonal antibodies, therapeutic vaccines, and checkpoint inhibitors. Key drivers are the rising incidence of cancer and advancements in immuno-oncology treatments. Checkpoint inhibitors are currently the largest treatment segment. North America is the largest market due to higher spending on cancer treatments and innovations in immuno-oncology. Major players in the market include Bristol Myers Squibb, Merck, AstraZeneca, and Roche.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global MarketsReportLinker.com
In the U.S., recent reimbursement changes and the economic downturn have called the expanding use of MRI scanning into question. The North American market is worth $2.3 billion in 2010 and is expected to increase at a 4.4% compound annual growth rate (CAGR) to reach $2.9 billion in 2015.Europe ranks with the U.S. as one of the most developed MRI markets. Expanding applications in the neurologic, cardiac, and breast MRI areas should drive the EU market. This sector is estimated at $1.2 billion in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $1.9 billion in 2015.Japan remains an early adopter of newer MRI equipment, making it a prime opportunity for newer 3T equipment. This market is valued at $1 billion in 2010 and should reach $1.3 billion in 2015, a compound annual growth rate (CAGR) of 4.3%.INTRODUCTIONREASONS FOR DOING THE STUDYMedical imaging costs make up one of the fastest-growing components of overall healthcare costs, and medical resonance imaging (MRI) is one of the leading imaging technologies used by healthcare providers.
This document provides an analysis of the Taiwanese medical device industry and investment opportunities. It discusses global trends showing the US market is the largest at 50.6% and growing. Taiwan's medical device industry generated $2.14 billion in revenue in 2006 from 500 companies. The document outlines gaps in Taiwan's supply chain and niche areas for foreign investors, as well as incentives for industry investment and examples of successful foreign investments and industry-academic collaborations in Taiwan.
The Current Oncology Pipeline: Development & LaunchHannah Law
The oncology treatment pipeline over the next four years promises a range of new treatment options across both solid and hematological cancers. There will be over 100 new molecules in phase III development by 2020, with 68% being targeted therapies that will further specialize cancer treatment. This exceptional level of launch activity will increase options for patients but requires healthcare payers and clinicians to better understand treatment pathways and patient populations. The large number of potential new treatments also necessitates reassessing how information about these expanded options is communicated to stakeholders.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
MarketResearchReports.com has announced the addition of “Forecast of Global Clinical Trial Supplies Consumption Market Report 2023” research report to their offering. See more at- http://mrr.cm/wWQ
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Healthcare, regulatory and reimbursement landscape israelsalisonline
GlobalData, the industry analysis specialist, has released its latest report, Healthcare, Regulatory and Reimbursement Landscape - Israel. An essential source of information and analysis on the Israeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
To read more ....http://www.salisonline.org/study/healthcare-regulatory-and-reimbursement-landscape-israel.asp#discription-tab
The document discusses the current state and expected growth trends of the in vitro diagnostics (IVD) market. It notes that the global IVD market was estimated at $54.2 billion in 2013 and is expected to grow 4% annually to $64.3 billion by 2018. Technological advances in areas like genomics, bioinformatics, and miniaturization have transformed diagnostic laboratory technology in recent years. Personalized medicine, infectious disease testing, and other applications are driving growth in the IVD market. However, economic instability, rising healthcare costs, and reimbursement changes pose challenges for the industry.
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
The global ureteral stents market size was valued at USD 423 billion in 2019 and is expected to reach USD 749 billion by 2028, expanding at a CAGR of 6.0% during the forecast period, 2021 – 2028. The growth of the market is attributed to the increasing cases of urological and kidney-related disorders.
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...IMARC Group
The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/ureteral-stents-market
The global immuno-oncology market is expected to exceed USD 38.89 billion by 2025, growing at a CAGR of 21.8%. Immuno-oncology or cancer immunotherapy enhances the body's natural defenses to stop cancer growth by using constituents made by the body or in a lab to improve immune system function. Key treatment approaches include monoclonal antibodies, therapeutic vaccines, checkpoint inhibitors, and cytokines while novel targets under investigation include IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, and more. The market is segmented by tumor type and region, with North America currently being the largest market due to high cancer treatment spending and innovation in immuno-oncology treatments.
The document provides an overview of the diagnostics market in Asia. It notes that the market is expected to grow at a CAGR of 8.5% between 2007-2008 due to factors such as increasing healthcare spending, aging populations, and demand for preventative healthcare tools. The largest regional markets are China, India, and Japan, though all markets are expected to see steady growth. The largest product segments are clinical chemistry, immuno-chemistry, and self-monitoring blood glucose devices.
Stent Market Report: Trends, Forecast and Competitive AnalysisLucintel
Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders. #StentMarket, #Stent
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
The document provides an overview of the diagnostics market in Asia from 2009-2010. It finds that the market is expected to grow at a CAGR of 8.5% due to factors like an aging population, increasing healthcare spending, and a shift toward preventative care. The largest national markets are China, expected to grow at 14.5% CAGR, and India at 12.1% CAGR. Leading segments are immunoassay, clinical chemistry and self-monitoring of blood glucose. Emerging areas of growth include molecular diagnostics, point-of-care testing and laboratory automation.
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body.
The global immuno-oncology market is expected to reach $38.89 billion by 2025, growing at a CAGR of 21.8%. Immuno-oncology harnesses the immune system to fight cancer through approaches like monoclonal antibodies, therapeutic vaccines, and checkpoint inhibitors. Key drivers are the rising incidence of cancer and advancements in immuno-oncology treatments. Checkpoint inhibitors are currently the largest treatment segment. North America is the largest market due to higher spending on cancer treatments and innovations in immuno-oncology. Major players in the market include Bristol Myers Squibb, Merck, AstraZeneca, and Roche.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global MarketsReportLinker.com
In the U.S., recent reimbursement changes and the economic downturn have called the expanding use of MRI scanning into question. The North American market is worth $2.3 billion in 2010 and is expected to increase at a 4.4% compound annual growth rate (CAGR) to reach $2.9 billion in 2015.Europe ranks with the U.S. as one of the most developed MRI markets. Expanding applications in the neurologic, cardiac, and breast MRI areas should drive the EU market. This sector is estimated at $1.2 billion in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $1.9 billion in 2015.Japan remains an early adopter of newer MRI equipment, making it a prime opportunity for newer 3T equipment. This market is valued at $1 billion in 2010 and should reach $1.3 billion in 2015, a compound annual growth rate (CAGR) of 4.3%.INTRODUCTIONREASONS FOR DOING THE STUDYMedical imaging costs make up one of the fastest-growing components of overall healthcare costs, and medical resonance imaging (MRI) is one of the leading imaging technologies used by healthcare providers.
This document provides an analysis of the Taiwanese medical device industry and investment opportunities. It discusses global trends showing the US market is the largest at 50.6% and growing. Taiwan's medical device industry generated $2.14 billion in revenue in 2006 from 500 companies. The document outlines gaps in Taiwan's supply chain and niche areas for foreign investors, as well as incentives for industry investment and examples of successful foreign investments and industry-academic collaborations in Taiwan.
The Current Oncology Pipeline: Development & LaunchHannah Law
The oncology treatment pipeline over the next four years promises a range of new treatment options across both solid and hematological cancers. There will be over 100 new molecules in phase III development by 2020, with 68% being targeted therapies that will further specialize cancer treatment. This exceptional level of launch activity will increase options for patients but requires healthcare payers and clinicians to better understand treatment pathways and patient populations. The large number of potential new treatments also necessitates reassessing how information about these expanded options is communicated to stakeholders.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
MarketResearchReports.com has announced the addition of “Forecast of Global Clinical Trial Supplies Consumption Market Report 2023” research report to their offering. See more at- http://mrr.cm/wWQ
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Healthcare, regulatory and reimbursement landscape israelsalisonline
GlobalData, the industry analysis specialist, has released its latest report, Healthcare, Regulatory and Reimbursement Landscape - Israel. An essential source of information and analysis on the Israeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
To read more ....http://www.salisonline.org/study/healthcare-regulatory-and-reimbursement-landscape-israel.asp#discription-tab
The document discusses the current state and expected growth trends of the in vitro diagnostics (IVD) market. It notes that the global IVD market was estimated at $54.2 billion in 2013 and is expected to grow 4% annually to $64.3 billion by 2018. Technological advances in areas like genomics, bioinformatics, and miniaturization have transformed diagnostic laboratory technology in recent years. Personalized medicine, infectious disease testing, and other applications are driving growth in the IVD market. However, economic instability, rising healthcare costs, and reimbursement changes pose challenges for the industry.
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
The global ureteral stents market size was valued at USD 423 billion in 2019 and is expected to reach USD 749 billion by 2028, expanding at a CAGR of 6.0% during the forecast period, 2021 – 2028. The growth of the market is attributed to the increasing cases of urological and kidney-related disorders.
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...IMARC Group
The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/ureteral-stents-market
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
Coronary stents global trends, estimates and forecasts, 2012-2018Research Hub
This document provides an overview and market analysis of the global coronary stents market from 2012-2018. Some key points:
- The global coronary stents market is projected to reach $9.5 billion by 2016, with North America and Europe currently making up around 70% of the total market value.
- Drug-eluting stents are expected to maintain over 55% of the global market share through 2015, with polymer stent coating being the fastest growing segment.
- The report analyzes the coronary stents market by type, coating, and geographic region, and provides growth rate forecasts for market segments. It also identifies investment opportunities and competitive strategies.
Guidewires are flexible and thin tubes that guide a catheter for placement in the diseased organ. Guidewires are used to open the target vessels, cross lesions and provide definitive interventional therapy to patients. Guidewires are the crucial components of vascular intervention with indispensable uses in the field of minimally invasive surgeries due to its capacity of rendering precise and effective results.
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...IMARC Group
The global intermittent catheters market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.
More Info:- https://www.imarcgroup.com/intermittent-catheters-market
Drug eluting stent market size, future demand, industry analysis and outlook ...Million Insights
The drug eluting stent market is projected to grow significantly due to increasing rates of atherosclerosis and lifestyle diseases in aging populations. Growth will be further driven by a shift from angioplasty procedures to the use of drug eluting stents, which are minimally invasive. However, declining prices and safety concerns regarding side effects of drug eluting stents may impede market expansion. The largest regional market is currently North America, though the Asia-Pacific market is anticipated to be the fastest growing due to improving healthcare infrastructure and increasing healthcare spending in the region.
Bariatric Surgery Devices Market PPT: Growth, Outlook, Demand, Keyplayer Anal...IMARC Group
The global bariatric surgery devices market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
More Info:- https://www.imarcgroup.com/bariatric-surgery-devices-market
The key drivers of the resectoscope industry include a rise in the female elderly population, an increase in the adoption of minimally invasive medical procedures, and growing technological advancements in resectoscopes. Resectoscopes are surgical instruments used to treat urogenital disorders and are integrated with cameras and extraction devices. However, advancing alternative technologies threaten the resectoscope segment. The largest resectoscope industry players are Cook Medical, Stryker, Olympus, and Boston Scientific.
Urinary Incontinence Devices Market PPT: Demand, Trends and Business Opportun...IMARC Group
The global urinary incontinence devices market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.66% during 2023-2028.
More Info:- https://www.imarcgroup.com/urinary-incontinence-devices-market
Urinary catheter is a tube used to collect urine from the bladder. The catheters are mostly recommended by the healthcare providers for people suffering from bladder disorders such as urinary incontinence and urinary retention. The catheters are usually made of latex, silicone, and polyurethane. Foley catheter comprises a balloon for holding the tube in the bladder for long term, whereas intermittent catheters provides short term catheterization. The urinary catheters are inserted into the urethra guiding through the bladder to drain out urine providing convenience to patients post-surgery. External catheters are advanced catheters preventing catheter associated urinary tract infections (CAUTI). Urinary catheters are also used during long surgical procedures for urine drainage for patients with other medical conditions such as spina bifida, multiple sclerosis and spinal injury, as the patients with neurological disease are at a risk for neurogenic lower urinary tract dysfunction known as neurogenic bladder.
Dental Diagnostics & Surgical Equipment and Forecast to 2025iGATE RESEARCH
iGATE Research has released a research report on “Dental Diagnostics & Surgical Equipment Market Outlook and Company Analysis - Global Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=135
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
PPT: Medical Cyclotron Market to Witness Huge Growth during 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical cyclotron market reached a value of US$ 192.6 Million in 2021. Medical cyclotron represents a type of particle accelerator, wherein an alternating electric field propels a beam of charged units in a spiral pattern. This assists in producing protons and radioactive isotopes for medical imaging, diagnosis, and treatment of various cardiovascular disorders.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Ureteral Stents Market
1. QUICK LINKS
About Us
Faq
Press Release
My account
Blog
Contact Us
How to order
Refund and Cancellation
Become A Reseller
POPULAR CATEGORIES
Aerospace & Defense
Consumer Goods
Energy & Power
Healthcare
ICT, Semiconductor & Electronics
Materials & Chemicals
CONTACTS
1st Floor, Kalpavruksha O ce No 1,
GK Lane Number 3, Ingawale Nagar,
Pimple Nilakh, Pune, Maharashtra
411027
+1 909 414 1393
sales@growthmarketreports.com
KEEP IN TOUCH
CONNECT WITH US
WE ACCEPT
Your email
Terms and conditions | Privacy | Growth Market Reports is Product of YOAAP Media Services LLP.
Home Medical Devices & Supplies Ureteral Stents Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Ureteral Stents Market
Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2021-2028
Ureteral Stents Market by Product Types (Open End Stents, Closed End
Stents, Double Pigtail Stents, and Multiloop Stents), Materials (Metallic
Ureteral Stents and Polymer Ureteral Stents {Silicone Stents, Polyurethane
Stents, and Hybrid Stents}), Applications (Kidney Stones, Kidney
Transplantation, Tumors, Urinary Incontinence, and Others), End-users
(Hospitals and Clinics), and Regions (North America, Europe, Asia Paci c,
Latin America, and Middle East & Africa) - Global Industry Analysis, Growth,
Share, Size, Trends, and Forecast 2021 – 2028
Report ID: HC-2286
Author: Growth Market Reports
Rating: 4.8
Total Reviews: 2
No. Of Pages: 174
Format:
Pub. Date: Upcoming
Share:
Report Description Table Of Content Segments Competitive Landscape Methodology
The global ureteral stents market size was valued at USD 423 billion in 2019 and is expected to reach USD 749 billion by 2028,
expanding at a CAGR of 6.0% during the forecast period, 2021 – 2028. The growth of the market is attributed to the increasing cases
of urological and kidney-related disorders.
XX XX XX XX XX XX XX XX XX
XX
XX
2018 H 2019 H 2020 A 2021 P 2022 P 2023 P 2024 P 2025 P 2026 P 2027 P 2028 P
Global Ureteral Stents Market Size (USD Million), Forecast and Y
-o-Y Growth, 2018-2028
CAGR: XX%
Source: Growth Market Reports Analysis
• Figure represents the global Ureteral Stents Market size and forecast from 2018 to 2028; wherein 2018 to 2019 are historic years, 2020 is the base/actual year and forecast is provided
from 2021 to 2028. The market is expected to grow at year-on-year growth rate of XX% between 2021 and 2028.
• Sample Content…Sample Content
• Sample Content…Sample Content.
Key Takeaways
Global Ureteral Stents Market
Infographic Data
Ureteral stents consist of a thin tube, which is placed into ureter and helps urine to ow from the kidney. Ureteral stents are used for
the treatment of kidney stones. Ureteral stents have two ends, namely, the upper part placed on the kidney and the opposite end
which is wrapped around the bladder. They are primarily used to allow urine to pass through the kidneys through obstruction of the
ureter and to relieve associated pain. Ureteral stents allow kidneys to function normally and leave the ureters open. They treat and
control conditions such as kidney stones, kidney transplants, and urinary incontinence.
Ureteral stents need to be replaced every 3-6 months, as stents cause multiple problems if placed in one place for too long such as:
Infections
Blocked ureter
Kidney stones
Market Trends, Drivers, Restraints, and Opportunities
Increasing cases of urological and kidney-related disorders is expected to propel the market during the forecast period.
Demand for ureteral stents increased, due to growing cases of kidney transplant cases.
Rising geriatric population is expected to drive the market during the forecast period.
Increasing incidences of prostate cancer are anticipated to drive the market during the forecast period, as ureteral stents are
required for treatment.
Demand for ureteral stents increased, due to changing lifestyles which include changing food habits and increasing intake of
calcium and alcohol. Negative lifestyle results in various health problems such as urolithiasis (kidney and ureteral stones) and
urinary incontinence, which is expected to drive the market during the forecast period.
Increasing awareness among people about advanced medical devices is anticipated to drive the market during the forecast
period.
Increasing investments and advancements in technology are expected to drive the market during the forecast period.
Increasing government expenditure in healthcare is anticipated to drive the market during the forecast period.
Di culties in removing ureteral stents are expected to hinder the market growth during the forecast period.
Development of ureteral stent products is anticipated to create multiple growth opportunities for the key players in the market
during the forecast period.
Scope of the Report
The report on the global ureteral stents market includes an assessment of the market, trends, segments, and regional markets.
Overview and dynamics have also been included in the report.
Attributes Details
Report Title Ureteral Stents Market - Global Industry
Analysis, Growth, Share, Size, Trends, and
Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2028
Segmentation Types (Open End Stents, Closed End
Stents, Double Pigtail Stents, and Multiloop
Stents), Materials (Metallic Ureteral Stents
and Polymer Ureteral Stents {Silicone
Stents, Polyurethane Stents, and Hybrid
Stents}), Applications (Kidney Stones,
Kidney Transplantation, Tumors, Urinary
Incontinence, and Others), End-users
(Hospitals and Clinics)
Geographical Scope North America, Asia-Paci c, Europe, Latin
America, and Middle East & Africa
Report Coverage Company Share, Market Analysis and Size,
Competitive Landscape, Growth Factors,
and Trends, and Revenue Forecast
Key Players Covered in the Report Boston Scienti c Corporation, COOK
MEDICAL LLC, B. Braun Melsungen AG, BD,
Coloplast Ltd., Merit Medical Systems, Inc.,
Olympus America, Tele ex Incorporated,
UROMED Kurd Drews KG, and Palex
Medical
Market Taxonomy
Global Ureteral Stents Market Segmental Insights
Based on types, the market is divided into open end stents, closed end stents, double pigtail stents, and multiloop stents. The double
pigtail stents segment is expected to hold a signi cant market share during the forecast period. Double pigtail stents are used in
endourologic procedures for treating pain, infections, and obstruction. Hence, rising number of endourologic procedures are expected
to drive the double pigtail stents segment during the forecast period.
On the basis of materials, the market is divided into metallic ureteral stents and polymer ureteral stents. Polymer ureteral stents is
further segmented into silicone stents, polyurethane stents, and hybrid stents. The polymer ureteral stents segment is anticipated to
expand at a considerable CAGR during the forecast period. Polymer ureteral stents are widely preferred by physicians and patients,
due to various bene ts associated with these stents such as enhanced exibility and biocompatibility. Polymer ureteral stents reduce
various complications and infections during implantation.
Based on applications, the market is divided into kidney stones, kidney transplantation, tumors, urinary incontinence, and others. The
kidney stones segment is expected to expand at a signi cant CAGR during the forecast period, owing to changing lifestyles such as
food habits, which cause various diseases such as urolithiasis. While treating kidney stones, ureteral stents are required for the
treatment of ureterorenoscopy (URS) and ureteroscopy.
XX%
XX%
XX%
XX%
XX%
Kidney Stones Kidney Transplanta on Tumors Urinary Incon nence Others
Market Share (%), by Applica ons, 2021
Source: Growth Market Reports Analysis
Based on end-users, the market is divided into hospitals and clinics. The hospitals segment is expected to hold a signi cant market
share during the forecast period. Factors such as increasing incidence of urological and kidney-related disorders, availability of
facilities for kidney transplants, and advancements in technologies are anticipated to propel the hospitals segment during the
forecast period.
Based on regions, the market is divided into North America, Asia Paci c, Europe, Latin America, and Middle East & Africa. North
America is expected to expand at a signi cant CAGR during the forecast period, owing to increasing urological and kidney-related
disorders such as urinary incontinence, kidney stones, and chronic kidney disease. Increasing government expenditure in healthcare is
anticipated to fuel the market during the forecast period in the region.
Europe, XX
Middle East & Africa, XX
Asia Pacific, XX
North America, XX
La n America, XX
CAGR
2020
-
27
Growth Poten al
Source: Growth Market Reports Analysis
Market A rac veness Analysis by Regions, 2021
Customize This Report
Ask for Research To Be Focused On
Speci c Regions or Segments
Receive Data As Per Your Format and
De nition
Companies Pro led based on Your
Requirements
Breaking Down Competitive
Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
Get in Touch with Us
+1 909 414 1393
sales@growthmarketreports.com
Buy Report
Single User $4200
Multi User $5200
Corporate User $6600
Online License $2999
Excel Data Pack $2599
Add to Cart
REQUEST FOR SAMPLE
ENQUIRY BEFORE BUYING
SPEAK WITH ANALYST
REQUEST FOR CUSTOMIZATION
We needed a highly accurate and
precise report, which Growth Market
Reports delivered promptly. The
company compiled information from a
wide array of reliable agencies and
sourcess.It is extremely satisfactory to
be working with you.
Strategy Head of Major Tech
Company
Oscilloscope Probe Market - Global Industry
Analysis, Size, Share, Growth, Trends And
Forecast
$4200
Vaccines Storage Equipment Market – Global
Industry Analysis, Size, Share, Growth, Trends
and Forecast
$4200
Veterinary Point of Care Blood Gas Analyzers
Market – Global Industry Analysis, Size,
Share, Growth, Trends and Forecast
$4200
Nitinol-based Medical Device Market –
Global Industry Analysis, Size, Share, Growth,
Trends and Forecast
$4200
Related Reports
Some other reports from this category!
B
0
C
E